Hillsdale Investment Management’s Bruker BRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-150
Closed -$13K 556
2021
Q4
$13K Sell
150
-7,500
-98% -$601K ﹤0.01% 538
2021
Q3
$598K Buy
7,650
+7,500
+5,000% +$624K 0.05% 359
2021
Q2
$11K Buy
+150
New +$10.5K ﹤0.01% 532
2019
Q4
Sell
-10,400
Closed -$457K 588
2019
Q3
$457K Sell
10,400
-500
-5% -$22.4K 0.04% 372
2019
Q2
$545K Buy
+10,900
New +$459K 0.05% 312
2017
Q4
Sell
-220
Closed -$7K 486
2017
Q3
$7K Hold
220
﹤0.01% 371
2017
Q2
$6K Sell
220
-100
-31% -$2.58K ﹤0.01% 373
2017
Q1
$7K Hold
320
﹤0.01% 371
2016
Q4
$7K Sell
320
-1,000
-76% -$21.9K ﹤0.01% 375
2016
Q3
$30K Sell
1,320
-13,100
-91% -$300K 0.01% 345
2016
Q2
$328K Sell
14,420
-1,000
-6% -$26.7K 0.1% 238
2016
Q1
$432K Buy
+15,420
New +$384K 0.15% 122

Other funds holding BRKR

Hillsdale Investment Management's BRKR Position: Q1 2022 in Review

Hillsdale Investment Management sold out of Bruker (BRKR) in Q1 2022, closing a stake of 150 shares — an estimated $13K sold.

Hillsdale Investment Management first reported a position in BRKR in Q1 2016 and held it in 12 quarters. The position peaked at $598K in Q3 2021. 311 funds tracked by Wall St. Rank hold BRKR as of Q1 2022.

  • Hillsdale Investment Management reported no remaining Bruker position as of Q1 2022 after selling out during the quarter.
  • Hillsdale Investment Management sold 150 Bruker shares in Q1 2022, an estimated $13K.
  • Hillsdale Investment Management first reported a position in Bruker in Q1 2016 and held it in 12 quarters.
  • Hillsdale Investment Management's Bruker position peaked at $598K in Q3 2021.
  • 311 funds tracked by Wall St. Rank held Bruker as of Q1 2022.

Based on Hillsdale Investment Management's 13F filing for Q1 2022, filed 28 Apr 2022.